在肥胖中对非标准炎症和代谢指数的综合评估:单一中心回顾性研究
Latife Merve Yildiz1, Bayram Kızılkaya2, Osman Cüre3
1Department of Family Medicine, Ordu University Faculty of Medicine, 52200 Ordu, Turkey.
Healthcare (Basel, Switzerland)
|November 27, 2025
概括
肥胖与炎症和代谢问题有关. 非标准指数如FIB-4和CRP/Alb与肥胖指标相关,为肥胖个体的代谢健康和纤维化提供了洞察力.
科学领域:
- 医学科学 医学科学 医学科学
- 临床研究 临床研究
- 生物标志物 生物标志物
背景情况:
- 肥胖是一个全球性的健康危机,通过慢性炎症驱动代谢和心血管疾病.
- 了解非标准的炎症和代谢指数对于管理与肥胖有关的并发症至关重要.
研究的目的:
- 评估肥胖个体的新型炎症/代谢标志物和临床因素之间的关联.
- 探索诸如SII,NLR,PLR,CRP/Alb,FIB-4,TG/HDL和TG/葡萄糖等指数在肥胖中的有用性.
主要方法:
- 对298名肥胖成年患者的回顾性分析.
- 收集人口,临床和实验室数据,包括血液学和生物化学参数.
- 计算衍生指数,例如CRP/Alb,TG/葡萄糖,FIB-4和SII.
主要成果:
- 体重指数与CRP/Alb正相关;年龄与FIB-4正相关,与SII负相关.
- FIB-4和SII显示出显著的负相关性.
- 在TG/HDL,TG/葡萄糖和PLR中观察到的性别差异;在糖尿病中CRP/Alb升高;在高血压和高脂血症中FIB-4更高.
结论:
- 非侵入性炎症和代谢指数与与肥胖相关的临床参数有显著的相关性.
- FIB-4,CRP/Alb和TG/HDL显示出作为评估肥胖中代谢和纤维化负担的补充工具的承诺.
- 这些指数为肥胖个体的炎症代谢概况提供了宝贵的见解.
更多相关视频
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
14.6K
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
885
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
162
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
162
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
620
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
620
